This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quach, C.
Right arrow Articles by Moore, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quach, C.
Right arrow Articles by Moore, D.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Influenza
PEDIATRICS Vol. 112 No. 3 September 2003, pp. e197-e201

ELECTRONIC ARTICLE

Risk Factors Associated With Severe Influenza Infections in Childhood: Implication for Vaccine Strategy

Caroline Quach, MD, FRCPC*, Lorraine Piché-Walker, RN*, Robert Platt, PhD{ddagger} and Dorothy Moore, MD, PhD, FRCPC*

* Infectious Disease Division, Department of Pediatrics, Province of Montreal Children’s Hospital, McGill University Health Center, Montreal, Province of Quebec, Canada
{ddagger} Department of Epidemiology and Biostatistics, McGill University, and the Montreal Children’s Hospital Research Institute, Montreal, Province of Quebec, Canada

Infections caused by influenza virus lead to an excess rate of hospitalization of children during winter months. Current recommendations for vaccination target only children >6 months who belong to specific risk groups.

Objective. To identify possible benefits of universal influenza vaccination, this study aims to determine characteristics of children hospitalized at the Montreal Children’s Hospital (MCH) because of an infection attributable to influenza virus as well as risk factors associated with hospitalization.

Methods. We retrospectively reviewed records of all children with a laboratory-proven diagnosis of influenza seen at MCH between April 1, 1999, and April 1, 2002. Data were analyzed using the Student t test and logistic regression.

Results. We identified 182 patients hospitalized because of influenza and 114 patients who were not. Admission diagnoses were suspected sepsis (31%), lower respiratory tract infections (27%), and asthma or bronchiolitis (15%). Mean age of hospitalized patients was 26.1 month (median: 12 months), which was similar to that of patients not hospitalized, and 34% were <6 months. Seventy percent of those hospitalized did not have any underlying medical disorder and only 18% (33) were vaccine candidates according to current recommendations. Of the latter, less than half had been vaccinated. Factors associated with hospitalization were age <12 months (odds ratio [OR]: 2.3; 95% confidence interval [CI]: 1.1–4.8), male gender (OR: 1.9; 95% CI: 1.0–3.7), dehydration (OR: 4.3; 95% CI: 1.2–16.0), and decreased oxygen saturation (OR: 32.1; 95% CI: 4.1–249).

Conclusions. Considering that the majority of children hospitalized for influenza do not belong to the specific risk groups targeted by current recommendations, and that one third are <6 months of age, the target population for vaccination needs to be reexamined. Extending vaccination to all young children, to additional high-risk groups, and to pregnant women has potential to reduce the impact of influenza on children.

Key Words: influenza • vaccine • pediatrics • and hospitalization

Abbreviations: MCH, Montreal Children’s Hospital • NPA, nasopharyngeal aspirate • DFA, direct immunofluorescent antigen assay • SD, standard deviation • ICU, intensive care unit • IV, intravenous • LOS, length of stay • OR, odds ratio • CI, confidence interval

Received for publication Feb 13, 2003; Accepted May 1, 2003.




This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
J. A. Rettew, Y. M. Huet-Hudson, and I. Marriott
Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity
Biol Reprod, March 1, 2008; 78(3): 432 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. L. Block, K. S. Reisinger, M. Hultquist, R. E. Walker, and for the CAIV-T Study Group
Comparative Immunogenicities of Frozen and Refrigerated Formulations of Live Attenuated Influenza Vaccine in Healthy Subjects
Antimicrob. Agents Chemother., November 1, 2007; 51(11): 4001 - 4008.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. Keren, T. E. Zaoutis, C. B. Bridges, G. Herrera, B. M. Watson, A. B. Wheeler, D. J. Licht, X. Q. Luan, and S. E. Coffin
Neurological and Neuromuscular Disease as a Risk Factor for Respiratory Failure in Children Hospitalized With Influenza Infection
JAMA, November 2, 2005; 294(17): 2188 - 2194.
[Abstract] [Full Text] [PDF]